Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

N/AEnrolling By InvitationNCT00628199

Stanford University60 enrolled

Overview

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

It is thought that studies of genetic reprogramming and SCNT using human cells have the potential to give us new basic knowledge about human development. Current work will focus on developing this basic knowledge. In the future, human embryonic stem cell lines (hESC) derived from genetic reprogramming and SCNT may also have the potential to develop into cell types that are useful for cell-based therapies to treat human disease and disability.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Metabolic Diseases Infertility

Interventions

Improving the scientific process of human cell reprogrammingPROCEDURE

Eligibility

Sex: ALLMin age: 1 YearMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure) Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.

Locations (1)

Stanford University School of Medicine

Stanford, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.